| Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.6132 | 1.8300 | 2.2200 | 1.3000 | 1.4400 | -18.64% |
| 2024 | 2.5648 | 4.5980 | 4.7240 | 1.3900 | 1.7700 | -60.14% |
| 2023 | 30.9449 | 85.8000 | 149.2000 | 3.4380 | 4.4400 | -93.79% |
| 2022 | 56.2198 | 94.8240 | 142.2000 | 31.6000 | 71.5000 | -20.64% |
| 2021 | 207.1179 | 249.6000 | 364.8000 | 88.8240 | 90.0960 | -62.83% |
| 2020 | 359.5612 | 439.2000 | 804.0000 | 216.0000 | 242.4000 | -44.51% |
| 2019 | 373.2992 | 518.4000 | 772.8000 | 242.4000 | 436.8000 | -9.00% |
| 2018 | 373.0474 | 315.6000 | 573.6000 | 280.8000 | 480.0000 | 61.29% |
| 2017 | 405.2902 | 422.4000 | 482.4000 | 297.6000 | 297.6000 | -27.06% |
| 2016 | 413.8130 | 434.4000 | 511.2000 | 352.8000 | 408.0000 | -11.04% |
| 2015 | 619.5256 | 614.4000 | 979.2000 | 415.2000 | 458.6400 | -34.10% |
| 2014 | 418.4561 | 273.5760 | 756.0000 | 247.2000 | 696.0000 | 202.08% |
| 2013 | 192.3138 | 273.6000 | 369.6000 | 120.0000 | 230.4000 | -15.79% |
| 2012 | 244.0685 | 290.3760 | 328.8000 | 156.0000 | 273.6000 | 0.01% |
| 2011 | 563.2843 | 993.6000 | 1180.8000 | 247.2000 | 273.5760 | -72.86% |
| 2010 | 1210.7000 | 960.0000 | 2395.2000 | 864.0000 | 1008.0000 | 0.00% |
| 2009 | 1075.4667 | 72.0000 | 1344.0000 | 72.0000 | 1008.0000 | 425.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GlycoMimetics (CBIO) | United States | $0.010B | 0.00 |
| Trimedyne (TMED.) | United States | $0.000B | 0.00 |